The Andersons, Inc. (ANDE) AI Stock Analysis
ANDE AI stock analysis summary
AI ResearchThe Andersons, Inc. is an agricultural company operating across grain merchandising, renewables, and plant nutrients. For the trailing twelve months, the company generated $10.94B in revenue with a net profit margin of 1.6%. ANDE shares returned 40.9% over the past year, outperforming the S&P 500 return of 16.8%.
- Market cap
- $2.21B
- Revenue (TTM)
- $10.94B
- P/E
- 12.5x fwd 20.9x
- 1Y return
- 40.9% S&P 500 16.8%
- Avg. target
- $86.67 33.5% vs last close
Bull case
- Quarterly earnings expanded 618.2% year-over-year in the period ended June 30, 2026.
- Analysts project fiscal 2026 EPS to increase 90.3% to $6.15, supported by 4 consecutive quarters of earnings beats.
- The shares trade at an EV/EBITDA multiple of 7.7x and trailing P/E of 12.5x, below the peer medians of 11.7x and 18.6x.
Bear case
- Annual revenue has declined for three consecutive fiscal years, sliding from $17.33B in FY2022 to $11.01B in FY2025.
- Free cash flow fell into negative territory at -$56.1M in FY2025 due to $233.1M in capital expenditures.
- Net profit margins remain thin, coming in at 1.6% for the trailing twelve months and 0.9% in FY2025.
What Andersons does
The Andersons, Inc. operates across trade, renewables, and plant nutrient sectors in the United States and internationally. Its Trade segment operates grain elevators, stores commodities, and provides marketing, risk management, merchandising, and logistics for commodities like corn, soybeans, wheat, oats, and domestic fuels. The Renewables segment produces, purchases, and sells ethanol and co-products, while managing ethanol facilities. The Plant Nutrient segment manufactures and distributes agricultural nutrients, liquid industrial products, and crop protection chemicals, alongside offering agronomic support services to farmers.
Growth and profitability
Annual revenue peaked at $17.33B in FY2022 before declining to $14.75B in FY2023, $11.26B in FY2024, and $11.01B in FY2025. Despite revenue falling 2.2% in FY2025, gross margin expanded to 6.5%, up from 3.5% in FY2021. Annual net income was $95.7M in FY2025, translating to diluted EPS of $3.24, compared to $114.0M and $3.47 in FY2024. Over the five years from FY2020 to FY2025, revenue grew at a CAGR of 6.4%. In the latest quarter ended June 30, 2026, quarterly revenue decreased 1.2% year-over-year, while quarterly earnings grew 618.2%, contributing to trailing twelve months EPS of $5.18.
Balance sheet and cash flow
As of June 30, 2026, The Andersons held $66.5M in cash and short-term investments against total debt of $900.8M, resulting in net debt of $834.2M. The company maintained a current ratio of 1.51 and a debt-to-equity ratio of 0.68 on $1.32B in shareholders' equity. Operating cash flow stood at $177.0M in FY2025, down from $331.5M in FY2024. Capital expenditures of $233.1M led to free cash flow of -$56.1M in FY2025, alongside $15.4M spent on share buybacks and $26.8M on dividends.
Valuation and performance
ANDE trades at a trailing P/E of 12.5x, below the median of its US-listed Consumer Defensive peers of 18.6x. However, its forward P/E of 20.9x is higher than the peer median of 14.3x. The stock trades at an enterprise value to EBITDA ratio of 7.7x compared to the peer median of 11.7x, and a price-to-sales ratio of 0.2x against the peer median of 0.7x. Over the past year, ANDE delivered a 40.9% return, outpacing the 16.8% return for SPY.
ANDE dividend
The company pays a quarterly dividend totaling an annualized $0.80 per share, offering a 1.23% dividend yield. The Andersons has paid dividends for 31 consecutive years, with a 5-year annualized dividend growth rate of 2.2%. Its dividend payout ratio stands at 13.0%, and the last ex-dividend date was October 1, 2026.
What analysts expect
All 3 analysts covering the stock rate it a StrongBuy. The mean price target is $86.67, representing a 33.5% upside from the last close of $64.93. For the fiscal year ending December 31, 2026, analysts estimate EPS of $6.15, representing 90.3% growth, on revenue of $11.62B. The company beat EPS estimates in all of the last 4 quarters, with next earnings scheduled for November 3, 2026.
Key risks and what to watch
- Operating cash flow declined to $177.0M in FY2025 from $331.5M in FY2024, limiting cash generation relative to debt.
- Total debt reached $900.8M as of June 30, 2026, compared to $66.5M in cash and short-term investments.
- Short interest accounts for 6.8% of the float, reflecting some negative sentiment in the market.
- The trailing twelve months operating margin is low at 1.6%, trailing the peer median of 9.8%.
AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer
About this ANDE AI stock analysis
This page is an AI-written research summary of The Andersons, Inc. (ANDE). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.
Related: ANDE income statement, ANDE balance sheet, ANDE key metrics, ANDE analyst forecast, ANDE chart. See the ANDE stock overview for the latest quote and news.
ANDE AI stock analysis FAQ
What was The Andersons' revenue in FY2025?
The Andersons reported revenue of $11.01B in FY2025, which was down 2.2% from $11.26B in FY2024.
Does The Andersons pay a dividend?
Yes, ANDE pays a quarterly dividend with an annualized forward rate of $0.80 per share, yielding 1.23% as of October 16, 2026. The company has paid dividends for 31 consecutive years.
What is the consensus analyst target price for ANDE stock?
The mean analyst price target is $86.67, which sits 33.5% above the closing price of $64.93 on October 16, 2026.
When does The Andersons report its next earnings?
The Andersons is scheduled to report its next earnings on November 3, 2026.